Nuclear factor-κB
- 1 December 2005
- journal article
- review article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 33 (Suppl) , S414-S416
- https://doi.org/10.1097/01.ccm.0000186079.88909.94
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- The effect of N-acetylcysteine on nuclear factor-κB activation, interleukin-6, interleukin-8, and intercellular adhesion molecule-1 expression in patients with sepsis*Critical Care Medicine, 2003
- Parthenolide improves systemic hemodynamics and decreases tissue leukosequestration in rats with polymicrobial sepsis*Critical Care Medicine, 2003
- Nuclear factor-κB as a therapeutic target in critical care medicineCritical Care Medicine, 2003
- Cyclooxygenase‐independent actions of cyclooxygenase inhibitorsThe FASEB Journal, 2001
- Transcription factor NF-κB as a potential biomarker for oxidative stressBritish Journal of Nutrition, 2001
- Impact of transcription factors AP-1 and NF-κB on the outcome of experimental Staphylococcus aureus arthritis and sepsisMicrobes and Infection, 2001
- Transcription Factor NFκB Expression and Postsurgical Organ DysfunctionAnnals of Surgery, 2001
- Increased nuclear factor κB activation in critically ill patients who dieCritical Care Medicine, 2000
- Role of NFkappaB in the mortality of sepsis.Journal of Clinical Investigation, 1997
- Nuclear factor-kappa B is activated in alveolar macrophages from patients with acute respiratory distress syndromeCritical Care Medicine, 1996